Filter Results:
(2,234)
Show Results For
- All HBS Web
(4,848)
- People (16)
- News (1,854)
- Research (2,234)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,819)
Show Results For
- All HBS Web
(4,848)
- People (16)
- News (1,854)
- Research (2,234)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,819)
Sort by
- 03 Nov 2003
- What Do You Think?
Can Investors Have Too Much Accounting Transparency?
insiders of the insider's equity..." Several respondents suggested the need for a careful approach to the issue of greater transparency. E. Smith asked, "Do investors care about immaterial... View Details
Keywords: by James Heskett
- 27 Aug 2014
- Lessons from the Classroom
Learning From Japan’s Remarkable Disaster Recovery
executives at dozens of organizations—Google and Yahoo!, health care organizations, even a knitting business in a fishing village. They've talked with public officials in Japan and the staff of the US... View Details
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- August 2008 (Revised May 2009)
- Background Note
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- 11 Oct 2024
- Research & Ideas
How AI Could Ease the Refugee Crisis and Bring New Talent to Businesses
instance, Paulson says she recently had a conversation with an executive MBA student who is designing a platform for matching patients with mental health care providers and wanted to learn from the... View Details
- 15 Aug 2005
- HBS Case
Classic Cases Live On at HBS
quality service, attention to patients, and an attractive work environment for doctors and staff—must be taken into account. By showing the positive impact of making health care more consumer-oriented,... View Details
Keywords: by Garry Emmons
- December 2007 (Revised July 2009)
- Case
Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?
GI has developed a revolutionary video pill for imaging the small bowel in the gastro-intestinal tract. The development has required the integration of wide variety of technologies. GI founder and CEO Gabriel Meron must determine GI's marketing strategy and prioritize... View Details
Keywords: Medical Specialties; Globalized Markets and Industries; Decisions; Technological Innovation; Marketing Strategy; Market Entry and Exit; Entrepreneurship; Health Care and Treatment; Corporate Finance; Medical Devices and Supplies Industry; Japan; United States; Europe
Isenberg, Daniel J. "Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?" Harvard Business School Case 808-033, December 2007. (Revised July 2009.)
- 22 Apr 2002
- Research & Ideas
Profits and Prophets: The Role of Values in Investment
provided a good return for a pension fund holder at some point, but that investor and society pay more in the end through increased health care costs. Hayes said that Domini's picture of a system run amok,... View Details
Keywords: by Sean Silverthorne
- 27 Dec 2015
- Research & Ideas
The Most Popular Stories and Research Papers of 2015
US Health Care? (18,291) Jim Heskett asks, are we addressing health care cost issues with the creativity they deserve? What do YOU think? How Should Pay Be Linked to... View Details
- October 2010
- Case
The Cleveland Clinic: Improving the Patient Experience (Abridged)
By: Ananth Raman, Anita L. Tucker and Rachel Gordon
Healthcare has traditionally focused on medical outcomes and financial performance. The big question is always, "How much is it going to cost?" What would happen though if healthcare also considered question of "How does the patient feel?" This case looks at the... View Details
Keywords: Customer Satisfaction; Ethics; Health Care and Treatment; Six Sigma; Performance Improvement; Safety; Value Creation
Raman, Ananth, Anita L. Tucker, and Rachel Gordon. "The Cleveland Clinic: Improving the Patient Experience (Abridged)." Harvard Business School Case 611-015, October 2010.
- 13 Apr 2020
- Research & Ideas
Small Businesses Are Worse Off Than We Thought
in-person operations, sinking demand to near zero. Professional services businesses have fared better, but they have not been spared—just 63 percent say they could weather a four-month public health lockdown. [div class=infogram-embed... View Details
- June 25, 2022
- Guest Column
CEOs Didn't Make the Roe Decision. It's Still Their Problem to Solve
By: Sandra Sucher
Keywords: Health Care and Treatment; Trust; Rights; Government Legislation; Social Issues; Employee Relationship Management; Corporate Social Responsibility and Impact; United States
Sucher, Sandra. "CEOs Didn't Make the Roe Decision. It's Still Their Problem to Solve." Barron's (June 25, 2022).
- 20 Jan 2017
- Research & Ideas
Here’s How Businessman Trump Is Likely to Approach the Presidency
different needs from small business. Small businesses have a more difficult time accessing capital, providing health care to their employees, navigating complex regulations at every level of government, and... View Details
Keywords: by Christina Pazzanese
- 26 Sep 2017
- First Look
First Look at New Research and Ideas, September 26, 2017
Leemore S., Igal Hendel, Victoria Marone, and Christopher Ody Abstract—Anecdotal reports and systematic research highlight the prevalence of narrow-network plans on the Affordable Care Act’s health insurance... View Details
Keywords: Sean Silverthorne
- 18 Jul 2017
- First Look
First Look at New Research and Ideas, July 18, 2017
between competitors in health care markets—whether payers or providers. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52843 May 2017 Strategic Organization Firms, Crowds, and Innovation... View Details
Keywords: Sean Silverthorne
- February 2016
- Case
Express Scripts: Promoting Prescription Drug Home Delivery (A)
By: John Beshears, Patrick Rooney and Jenny Sanford
The pharmacy benefit manager (PBM) sector processes prescription drug claims on behalf of companies that offer a prescription drug benefit to their employees. This case follows Bob Nease, Chief Scientist at Express Scripts, as he considers methods to promote home... View Details
Keywords: Pharmaceuticals; Prescription Drugs; Pharmacy Benefit Manager; PBM; Healthcare; Behavioral Economics; Choice Architecture; Active Choice; Service Delivery; Decision Choices and Conditions; Health Care and Treatment; Order Taking and Fulfillment; Compensation and Benefits; Pharmaceutical Industry
Beshears, John, Patrick Rooney, and Jenny Sanford. "Express Scripts: Promoting Prescription Drug Home Delivery (A)." Harvard Business School Case 916-026, February 2016.
- 2024
- Working Paper
Magnetic Resonance Imaging—High Quality and Radiation Free: Case Histories of Transformational Advances
By: Srikant M. Datar, Amar Bhidé and Katherine Stebbins
This case history describes how Magnetic Resource Imaging (MRI) came to complement – and partially replace -- computed tomography (CT) imaging of soft tissue. Specifically, we chronicle 1) the development of foundational techniques and prototypes (through the 1970s);... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Datar, Srikant M., Amar Bhidé, and Katherine Stebbins. "Magnetic Resonance Imaging—High Quality and Radiation Free: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-001, July 2019. (Revised May 2024.)
- 2024
- Working Paper
Mammography - Early Detection, Precise Diagnoses: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how the development of x-ray-based techniques and equipment (“mammography”) led to widespread screening for breast cancer and enabled “minimally invasive” biopsies of breast tumors. Specifically, we chronicle how: 1) new protocols and... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Mammography - Early Detection, Precise Diagnoses: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-002, July 2019. (Revised May 2024.)
- 2024
- Working Paper
Antibiotic Treatments for Ulcers--Eradicating H-Pylori Infections: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how a chance discovery of bacteria that infect stomach linings completely changed how physicians treat ulcers. Specifically, we chronicle how: 1) two Australian physicians brought the bacterial infection to the world’s attention and... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Antibiotic Treatments for Ulcers--Eradicating H-Pylori Infections: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-006, July 2019. (Revised May 2024.)